亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Effect of thymosin α1 for advanced non-small-cell lung cancer in chemotherapy patients

作者
Meilin Liao
出处
期刊:China Oncology [Fudan University Shanghai Cancer Center]
被引量:1
摘要

Purpose:To evaluate the effects of thymosin α1 (Tα1) in chemotherapy of NSCLC. Methods:We have conducted a prospective randomized controlled clinical trial.40 non-treated cases of stage Ⅲ-Ⅳ NSCLC were randomized into Tα1 group ( chemotherapy combined with thymosin α1) and control group (chemotherapy alone). The number of T cell subgroups, the activity of NK cell and phagocytic index of neutrophilic granulocyte in peripheral blood were detected and quality of life and changes of cancer lesions were evaluated before and after treatment. Results:After treatment,the levels of CD4 in the Tα1 group was significantly higher than before treatment(P0.05). After treatment,the natural killer(NK) activity in the control group was significantly lower than before treatment(P0.05). After chemotherapy, phagocytic index of the Tα1 group was significantly higher than that of the control group(P0.05).Overall response rate was 50% in the Tα1 group and 35% in the control group, but there was no statistically significant difference(P0.05). There was no significant difference of myelosuppression between the two groups. No infections or severe toxicity occurred in the Tα1 group. One severe lung infection was seen in the control group.There was better quality of life for the Tα1 group compared with the control group(P0.05). Prognosis of the Tα1 group was better than that of the control group. MST was 22.1 months in the Tα1 group and 12.0 months in the control group.1-year survival for the Tα1 group and the control group was 84.21% and 50.00%, respectively. 3-year survival for the Tα1 group and the control group was 27.72% and 14.29%, respectively. Conclusions:The immunological function of NSCLC is significantly elevated by Tα1 treatment. This trial indicates that chemotherapy combined with thymosin α1 for the treatment of NSCLC can improve patients’ quality of life and prolong survival.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
9秒前
直率水儿完成签到,获得积分10
18秒前
foxm完成签到,获得积分10
23秒前
33秒前
42秒前
stephanie_han完成签到,获得积分10
43秒前
稳重听荷完成签到,获得积分10
43秒前
加把劲骑士完成签到,获得积分10
46秒前
万霖发布了新的文献求助10
47秒前
科研民工完成签到,获得积分10
54秒前
56秒前
57秒前
null的应助被科研通管家采纳,获得20
57秒前
Ttimer完成签到,获得积分10
1分钟前
丘比特的应助被万霖采纳,获得10
1分钟前
贪玩千儿完成签到,获得积分10
1分钟前
1分钟前
魔幻的松思完成签到,获得积分10
1分钟前
冷艳千柳完成签到,获得积分10
1分钟前
1分钟前
感性的念之完成签到,获得积分10
2分钟前
2分钟前
2分钟前
坚定百褶裙完成签到,获得积分10
2分钟前
2分钟前
漂亮的幻枫完成签到,获得积分10
2分钟前
Crisp完成签到 ,获得积分0
2分钟前
枕月完成签到,获得积分10
3分钟前
精明凝海发布了新的文献求助10
3分钟前
悲凉的丝完成签到,获得积分10
3分钟前
3分钟前
饱满飞绿完成签到,获得积分10
3分钟前
ajing发布了新的文献求助10
3分钟前
朴实水云完成签到,获得积分10
3分钟前
3分钟前
3分钟前
枕月发布了新的文献求助10
4分钟前
生动的依白完成签到,获得积分10
4分钟前
AnYX完成签到 ,获得积分10
4分钟前
震动的醉蓝完成签到,获得积分10
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179896
求助须知:如何正确求助?哪些是违规求助? 9570103
关于积分的说明 21808343
捐赠科研通 7775692
什么是DOI,文献DOI怎么找? 3433193
关于科研通互助平台的介绍 2557334
邀请新用户注册赠送积分活动 2478881